Strata Critical Medical closes Passenger sale to Joby for ~$76M in stock; shifts to medical transport

Strata Critical Medical, Inc.

Completed sale of Passenger business to Joby Aero on Aug 29; received ~$76M in 5.3M Joby shares, plus up to $35M earnout and $10M holdbacks.
Name changed to Strata Critical Medical; Nasdaq tickers become SRTA (common) and SRTAW (warrants).
Melissa Tomkiel and William Heyburn appointed co-CEOs; both join Board; directors Borthwick and Lerer resigned.
Pro forma shows continuing ops net loss of $1.45M for H1 2025 vs $7.24M reported, reflecting Passenger divestiture.
Company issued updated FY2025 financial guidance; see press release Exhibit 99.2 for details.

item 1.01item 2.01item 5.02item 5.03item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.